Emmanuel Quinaux

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Christophe Tournigand, Thierry André, Emmanuel Achille et al. · Journal of Clinical Oncology · 2003 · 2.9K citations · Full text

Medicine, Oncology, Pharmacology +13

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

Sherene Loi, Nicolas Sirtaine, Fanny Piette et al. · Journal of Clinical Oncology · 2013 · 1.6K citations

Medicine, Immunology, Oncology +17

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Christophe Tournigand, Thierry André, Emmanuel Achille et al. · Journal of Clinical Oncology · 2023 · 191 citations

Medicine, Oncology, Pharmacology +13

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

Evandro de Azambuja, Worta McCaskill‐Stevens, Prudence A. Francis et al. · Breast Cancer Research and Treatment · 2009 · 160 citations

Medicine, Oncology, Breast Oncology +14

Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1

Thierry André, Emmanuel Quinaux, Christophe Louvet et al. · Journal of Clinical Oncology · 2007 · 156 citations

Medicine, Oncology, Pharmacotherapy +15